Abstract:Objective To investigate the clinical efficacy of the treatment of long-term non-invasive positive pressure ventilation (NIPPV) combined with inhaling corticosteroids in patients with stable chronic o0bstructive pulmonary disease(COPD) complicated with respiratory failure,and to investigate the impact of longterm NIPPV combined with inhaling corticosteroids on serum levels of matrix metalloproteinase-9 (MMP-9).Methods Eighty outpatients of stable severe COPD complicated with respiratory failure divided them equally into two treatment groups (the experimental and the control groups).The two groups of patients were given oxygen therapy,inhalation of Salmeterol and fluticasone propionate powder for one year.The experimental group received additionally NIPPV therapy for 1 year.The outcomes measured included St.George's questionnaire (SGRQ) score,MMRC score,6-min working time (6-MWT),arterial partial pressure of oxygen (PaO2),partial pressure of carbon dioxide(PaCO2),Forced expiratory volume in 1 (FEV1％),and the serum levels of MMP-9 before and after treatment,and frequency of acute exacerbations of COPD and hospital says in the last one year and the following 12 months.Results After 1 year,the differences of SGRQ score,MMRC score,6-MWT,PaO2,PaCO2,FEV1％,MMP-9 in the experimental group ((63.38 ±4.46) vs.(52.93 ±4.30),t =10.67,P =0.00;(3.60±0.50) vs.(2.40 ±0.50),t =10.82,P=0.00;(159.90 ±6.50) m vs.(247.10±9.66) m,t=47.39,P=0.00;(56.85 ± 1.67) mm Hg vs.(66.10 ±2.59) mm Hg,t =10.67,P =0.00;(60.38 ±3.58)mm Hgvs.(51.88 ±3.05)mm Hg,t=10.82,P=0.00; (38.93 ±3.22)％ vs.(42.12 ±3.11)％,t=47.39,P =0.00;(182.58 ±6.60) μg/L vs.(171.73 ±6.19) μg/L,t =7.58,P =0.00) were statistically significant compared to the control group ((63.88 ± 4.88) vs.(54.30 ± 4.13),t =8.77,P =0.00; (3.65 ± 0.48) vs.(2.70±0.46),t =8.97,P =0.00;(157.98 ±5.97) m vs.(218.08±13.12) m,t =26.38,P=0.00;(56.65 ±1.51)mm Hg vs.(62.60 ± 1.91)mm Hg,t=8.77,P=0.00; (60.20 ±3.52)mm Hg vs.(56.25 ±3.09)mm Hg,t =8.97,P =0.00; (38.93 ±2.96) ％ vs.(40.70 ±3.27)％,t =26.38,P =0.00; (180.55 ±4.78) μg/L vs.(173.05 ± 5.28) μg/L,t =6.66,P =0.00).The frequency of acute exacerbations of COPD and hospital stay days were significantly decreased in the experimental group than in the control group.Conclusion Long-term NIPPV combined with inhaling corticosteroids could significantly improve the quality of life and lower the serum levels of MMP-9 of patients with severe stable COPD complicated with respiratory failure. Key words: Chronic obstructive pulmonary disease; Respiratory failure; Non-invasive positive pressure ventilation; Corticosteroids; Matrix metalloproteinase-9

Clinical Investigation of Non-Invasive Positive Pressure Ventilation in Treatment for Patients with Chronic Obstructive Pulmonary Disease and Severe Respiratory Failure Complicated with Hypercapnia

Evaluation of the Effectivenesss of Noninvasive Positive Pressure Ventilation As a Weaning Strategy in Patients with Acute Respiratory Failure

Non-invasive Positive Ventilation in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Hypercapnia Respiratory Failure

Efficacy and Impact on Serum Matrix Metalloproteinase-9 of Long-Term Non-Invasive Positive Pressure Ventilation Combined with Inhaling Corticosteroids in Patients with Stable Severe Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

The Clinical Value of Noninvasive Ventilation in Chronic Hypercapnic Respiratory Failure--a 3-Year Retrospective Study

Long term noninvasive positive pressure ventilation in patients with severe stable chronic obstructive pulmonary disease

Clinical Investigation of Non-Invasive Positive Pressure Ventilation in Patients with Severe Asthma

A Clinical Observation with Noninvasive Positive Pressure Mechanical Ventilation on COPD Elderly Patients with Type II Respiratory Failure

Efficacy and Safety of Noninvasive Positive Pressure Ventilation in the Patients with Respiratory Failure Due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Conscious Disturbances

Application of Noninvasive Positive-Pressure Ventilation in Patients With Acute Respiratory Failure After Cardiopulmonary Bypass Surgery

Noninvasive positive pressure ventilation in the treatment of cardiothoracic patients with acute respiratory failure

Clinical efficacy of HI-NPPV in the treatment of AECOPD combined with severe type II respiratory failure

Application of Bi-level Noninvasive Positive Pressure Ventilation in Patients of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure

Effect of Bronchial Lavage Combined with Non-Invasive Positive Pressure Ventilation in Rescuing of Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients

Noninvasive positive pressure ventilation (NPPV) therapy for elderly patients with moderate and severe COPD

[Prospective Randomized Controlled Clinical Study of Early Use of Noninvasive Positive Pressure Ventilation in the Treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease].

[The Efficacy and Safety of Long Term Home Noninvasive Positive Pressure Ventilation in Patients with Stable Severe Chronic Obstructive Pulmonary Disease].

Observation on the Effect of Non-Invasive Ventilator Combined with Conventional Therapy in the Treatment of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Respiratory and Circulating Effects of Noninvasive Positive Pressure Ventilation in the Post-operation Patients with Acute Respiratory Failure

Noninvasive Ventilator in the Old AECOPD Combination of Respiratory Failure the Clinical Value

Evaluation of Noninvasive Ventilation in Treatment of Patients with Severe Asthma